Healthcare -
Biotechnology - NASDAQ - US
$ 0.91
9 %
$ 49.6 M
Market Cap
11.38
P/E
SPRO - CASH FROM OPERATIONS
Cash from Operations SPRO - Spero Therapeutics, Inc.
-33 M
LAST VALUE
28.39%
2 YEAR CAGR
3.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR